Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Tuesday, March 10, 2015
A US Regulator’s View on Abuse Deterrent Formulations of Opioids Douglas C. Throckmorton, MD Deputy Director for Regulatory Programs, CDER, FDA CADCA National Leadership Forum February 3, 2015
No comments:
Post a Comment